| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 91,480 | 62,348 | 53,284 | 64,542 | | Cost of Revenue |
-
| (43,473) | 43,473 | 83,762 | | | Gross Profit | 91,480 | 105,821 | 9,811 | (19,220) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 80,560 | 99,752 | 6,309 | 7,596 | | Non Recurring |
-
|
-
|
-
| 59,043 | | Others | 3,174 | 3,307 | 3,287 | 4,038 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,746 | 2,762 | 215 | (89,897) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,661 | 3,550 | (378) | 1,751 | | Earnings Before Interest And Taxes | 11,110 | 6,025 | (609) | (91,565) | | Interest Expense | 3,799 | 4,402 | 4,657 | 4,914 | | Income Before Tax | 7,311 | 1,623 | (5,266) | (96,479) | | Income Tax Expense | 2,254 | 563 | (1,556) | (29,371) | | Minority Interest | 2 | 4 | 1 | 1 | | | | Net Income From Continuing Ops | 5,052 | 1,064 | (3,709) | (67,107) | | | Non-recurring Events | | Discontinued Operations | (5) | 24 | 158 | (397) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,054 | 1,088 | (3,551) | (67,504) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,054 | $1,088 | ($3,551) | ($67,504) |
|
0.26% Nasdaq 
Income Statement
